
Biotechnology and Applied Biochemistry (1999) 30, (5964) (Printed in Great Britain)
Expression and purification of a secreted functionalmouse/human chimaeric antibody against bacterial endotoxin inbaculovirus-infected insect cells
Weiqi Tan*1 and Peter H. Y. Lam†
*National Laboratory of Biomembrane and MembraneBiotechnology, Institute of Zoology, Academia Sinica, Beijing100080, People's Republic of China, and †Department ofBiochemistry, Hong Kong University of Science and Technology,Hong Kong, People's Republic of China
Abbreviations used: Fab, antigen-binding fragment; Fc,
crystallizing fragment; Fd, heavy-chain fragment VHCH1;
HAMA, human anti-mouse antibody; HC, heavy-chain gene; LC,
light-chain gene; mAb, monoclonal antibody; PNGase F, peptide
N-glycosidase F.
1 To whom correspondence should be addressed.
We have created a mouse/human chimaeric antibody by taking
antigen-binding fragment (Fab) genes of a mouse
antibody-producing hybridoma with specificity for bacterial
endotoxin and joining them to human Ig crystallizing-fragment (Fc)
genes using recombinant DNA techniques. This chimaeric antibody
has been expressed in Sf21 and High Five™ (BTI-TN-5B1-4) insect
cells using the baculovirus expression system, which may allow
the mass production of secretory recombinant antibodies. This was
achieved by using infection with a double-recombinant virus
containing cDNAs of both the Ig heavy-chain (HC) and
light-chain (LC) genes. Prior to recombination, each gene
was cloned into the dual-expression baculovirus transfer vector
pPLSP2, which permitted the insertion of the LC gene
in-frame with the signal peptide of honey bee melittin downstream
of the polyhedrin promoter, and of the HC gene in-frame
with the signal peptide of Bombyx mori larval serum
protein downstream of the p10 promoter. Our results showed that
the polypeptide chains were secreted by insect cells and
correctly assembled into H2L2 heterodimers
containing N-linked carbohydrate at the heavy chain. Furthermore,
the recombinant chimaeric antibody exhibited a similar antigen
specificity to that of the monoclonal antibody. More importantly,
it provides a generic method for the high-level expression of
antibodies.
Received 10 March 1999/16 April 1999; accepted 4 May 1999
Portland Press Ltd © 1999
|